Neuroanesthesia & neurocritical care

Effects of remimazolam and propofol on sleep rhythm and delirium after spinal surgery in elderly patients

Perioper Med (Lond)Published Comparative clinical study

Authors' conclusion

The use of remimazolam in elderly patients undergoing spinal surgery has a minimal impact on postoperative melatonin and cortisol secretion rhythms and sleep patterns, and may reduce the incidence of POD and alleviate postoperative sleep disturbances.

Study context

Population
Elderly patients scheduled for elective spinal surgery (posterior lumbar interbody fusion) under GA, November 2023 to January 2024
Participants
120 patients
Comparison
Remimazolam vs propofol for induction and maintenance of GA
  • Rn = 60
  • Pn = 60reference

Main finding

As reported in the abstract

  • Melatonin concentrations significantly higher, cortisol significantly lower and Pittsburgh Sleep Quality Index (PSQI) scores significantly reduced in R vs P at 04:00 on postoperative delirium (POD) 1 and 2 (P < 0.05)
  • Incidence of POD and postoperative sleep disturbance significantly lower in R vs P (P < 0.05)

Further findings

Extubation time and PACU stay

Significantly shorter in R vs P (P < 0.05)

PSQI and resting visual analog scale (VAS) pain scores · postoperative day 1

Significantly lower in R vs P (P < 0.05)

Surgery and anaesthesia duration, total and effective analgesia pump presses, supplemental analgesia rates

No statistically significant differences between groups (P > 0.05)

Safety

Intraoperative hypotension, postoperative nausea, vomiting, dizziness and respiratory depression

No statistically significant differences between groups (P > 0.05)

Original publication

Effects of remimazolam and propofol on sleep rhythm and delirium after spinal surgery in elderly patients. Perioper Med (Lond). Published 11 February 2025. doi:10.1186/s13741-025-00500-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.